ADARx Pharmaceuticals (ADRX) Finishes 13.8% Above IPO Price After Strong Opening
Eric Friedman
Shares open 30% above the $17.00 IPO price before giving back much of the initial gain, while IPO Prophet's sentiment model remains Neutral throughout the session.
September 25, 2026
ADARx Pharmaceuticals Inc. (Nasdaq: ADRX) delivered a strong opening in its public-market debut, opening at $22.10, exactly 30.0% above its $17.00 IPO price. The company priced at the top of its marketed $15.00-$17.00 range and increased the offering to 26.25 million shares, raising $446.25 million.
The strong opening reflected significant initial demand, with ADRX reaching an intraday high of $23.21. However, the early strength did not hold. Shares gradually moved lower during the session before selling accelerated later in the afternoon, eventually taking ADRX to an intraday low of $19.05.
Neutral Sentiment Throughout the Session
Despite the deterioration in price, IPO Prophet's quantitative sentiment model opened Neutral and remained Neutral throughout the entire trading session. No Bearish Sentiment signal was generated.
That distinction is important. While ADRX gave back a meaningful portion of its opening premium, the price action did not meet IPO Prophet's threshold for a bearish signal.
ADRX ultimately closed at $19.35, down 12.44% from its $22.10 opening price, but still 13.82% above its $17.00 IPO price. The session therefore produced two very different perspec
